Innate Pharma's Overnight €30m Capital Raise Sends Shares Down 18%
Companies

Innate Pharma's Overnight €30m Capital Raise Sends Shares Down 18%

The French biotech priced a €30m equity raise at €1.70 per share, a 15% discount, to fund its IPH4502 ADC programme; inv...

Declan Byrne 👁 44 💬 0
FDA Clears AI Coronary Inflammation Tool; Hofstra Sued Over Bar-Exam Cardiac Arrest
Health

FDA Clears AI Coronary Inflammation Tool; Hofstra Sued Over Bar-Exam Cardiac Arrest

Caristo's CaRi-Heart wins FDA de novo clearance, Hofstra faces a cardiac-arrest lawsuit over bar-exam emergency care, an...

Noa Feldman 👁 30 💬 0
Trial Finds Ozempic, Wegovy Drug Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder
Health

Trial Finds Ozempic, Wegovy Drug Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder

A 50-patient University of Colorado trial found oral semaglutide reduced heavy drinking and cravings, a step toward the ...

Noa Feldman 👁 44 💬 0
Bepirovirsen Yields Functional Cure in 1 in 5 Hepatitis B Patients in Pivotal Trial
Health

Bepirovirsen Yields Functional Cure in 1 in 5 Hepatitis B Patients in Pivotal Trial

Phase 3 results show the investigational antisense drug bepirovirsen eliminated HBsAg and viral DNA for at least 24 week...

Noa Feldman 👁 30 💬 0